Position in NKTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,926,694
+$2,525,519 QoQ
Shares Held
3,507,666
0.0% QoQ
Ownership
4.90%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#4
of 136 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SAMSARA BIOCAPITAL, LLC holds $1,139,869,255 across 22 Biotechnology names. NKTX ranks #13 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
6,897,652 | $379,370,860 | |
| 2 | ALMS |
Alumis Inc.
|
6,345,219 | $178,554,462 | |
| 3 | MLYS |
Mineralys Therapeutics, Inc.
|
5,871,018 | $158,400,065 | |
| 4 | SEPN |
Septerna, Inc.
|
3,149,128 | $105,464,296 | |
| 5 | NGNE |
Neurogene Inc.
|
1,717,127 | $54,003,644 | |
| 6 | KLRS |
Kalaris Therapeutics, Inc.
|
12,881,175 | $52,426,382 | |
| 7 | SGP |
SpyGlass Pharma, Inc.
|
2,109,953 | $46,967,553 | |
| 8 | STRO |
Sutro Biopharma, Inc.
|
1,062,872 | $35,287,350 |
All Filings in NKTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,926,694 | 3,507,666 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,401,175 | 3,507,666 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,489,182 | 3,507,666 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,799,832 | 3,768,035 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,254,938 | 3,768,035 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,933,184 | 3,768,035 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,382,407 | 3,768,035 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,031,518 | 3,768,035 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,269,086 | 3,768,035 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $40,732,458 | 3,768,035 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $18,929,031 | 2,868,035 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,986,568 | 2,868,035 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,280,996 | 2,868,035 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $10,181,524 | 2,868,035 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $17,179,529 | 2,868,035 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $37,743,340 | 2,868,035 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $35,334,191 | 2,868,035 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $23,154,908 | 2,034,702 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $31,232,691 | 2,034,703 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $56,585,090 | 2,034,703 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $64,479,738 | 2,034,703 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $66,941,728 | 2,034,703 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $125,073,193 | 2,034,703 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $61,163,172 | 2,034,703 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||